Bausch + Lomb Corp sees slight gains this week amidst leadership changes and optimistic market outlook.
This week, Bausch + Lomb Corp (BLCO.TO) experienced a modest price increase of 0.34%, closing at C$23.49. The stock's recent performance has been influenced by company news and market sentiment regarding its future prospects.
Advertisement
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeAdvertisement
Market cap
$8.43B
52W high
$25.70
52W low
$19.36
1W change
+0.34%
Beta
0.55
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to rise 6.9% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.10
+6.9% Upside
Current Price
C$23.49
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
31.4%
Annualized
90-Day Vol
28.7%
Annualized
Trend (90d)
+23.2%
Annualized drift
90d Mean
C$25.52
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$24.15 | C$21.67 – C$26.91 |
| 60 trading days | C$24.82 | C$21.30 – C$28.93 |
| 90 trading days | C$25.52 | C$21.15 – C$30.78 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should note the recent leadership changes and the reaffirmation of guidance as potential catalysts for future stock performance. The stock's technical indicators suggest a stable position within its 52-week range, but the overall financial metrics indicate challenges that may need to be addressed.
C$23.49
Last close reflects a slight decrease of 0.42% in one day, while showing a year-to-date gain of 3.07%.
Bull case
The appointment of Thomas J. Appio, the CEO of Bausch Health, to the Bausch + Lomb board could signal a strategic shift aimed at improving the company's performance and market position. Additionally, the stock's average analyst target suggests a potential upside, indicating that some analysts are optimistic about the company's future.
Bear case
Despite the recent leadership changes, Bausch + Lomb continues to report negative profit margins and a declining return on equity, which may deter some investors. The lower trading volume compared to the 20-day average also raises concerns about investor confidence.
Recent Price Action
Advertisement
Bausch + Lomb Corp (BLCO.TO) has seen a slight decline of 0.42% in the last trading day, closing at C$23.49. However, the stock has managed to gain 0.34% over the past week and has increased by 3.53% over the past month, indicating a gradual upward trend despite minor fluctuations.
Company News and Catalysts
Recent developments have included the appointment of Thomas J. Appio, the CEO of Bausch Health, to the Bausch + Lomb board, which may provide a fresh perspective and strategic direction for the company. Additionally, Bausch + Lomb has reaffirmed its guidance, suggesting confidence in its operational outlook. Analysts are moderately bullish, with an average target price of C$25.10, indicating a potential upside from the current levels.
Technical Picture
Bausch + Lomb's stock is currently trading at C$23.49, which is approximately 3.7% above its 50-day moving average of C$22.64 and 3.5% above its 200-day moving average of C$22.70. The stock has a 52-week range of C$19.36 to C$25.70, placing it at 65% of its range. With a beta of 0.55, the stock exhibits lower volatility compared to the market. However, the recent trading volume of 400 shares is significantly below the 20-day average of 1,595 shares, indicating reduced trading activity.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
